InvestorsHub Logo
Followers 4
Posts 1510
Boards Moderated 0
Alias Born 08/23/2010

Re: Jayyy post# 7103

Tuesday, 09/27/2016 11:43:50 AM

Tuesday, September 27, 2016 11:43:50 AM

Post# of 13735
Each time the Consumer Reports article has been posted as supposed evidence that FDA warns against Sucanon or 'types of products' like Sucanon, the subject sentence is left out of the middle of the claimed "verbatim excerpt" (post 6475, 6489 and others).

It reads : "It warned 15 companies last week about the illegal marketing of certain diabetes products, including Glucocil, Glytain, ProBeta’s Gynmena Sylvestre, and Zostrix Joint and Arthritis Pain Relief Cream. " Note that Sucanon is not mentioned in the article and has not been sold in the US.

Further, IF the article was applicable, why would it be necessary to leave out the subject sentence? It is claimed a "verbatim excerpt" when it is not which leads to a false conclusion. That is a notorious omission and the falsity easily and definitively established.

Read the complete unedited article here:

http://www.consumerreports.org/cro/news/2013/07/diabetes-treatment-alternatives/index.htm

Let's consult the definition of verbatim: "in exactly the same words that were used originally", which your post is clearly not. More disturbing, when the error is pointed out, it is incorrectly repeated again for the stated purpose of "scaring others away" as stated in post 4550.

This is further evidence of my contention that no credible information has been put forth of a scam or fraudulent actions by this company. If the "evidence" has to have the subject sentence removed while falsely claiming a "verbatim excerpt" and attempting to lead others to an incorrect conclusion, then that is not evidence at all. In court it would be false testimony. If the company is a scam and fraudulent as claimed, there would be plenty of supporting information for those claims. Instead, information is falsely and surreptitiously edited to make it appear to support the false claim and conclusion as above.